|
Forecast Period
|
2026-2030
|
|
Market Size (2024)
|
USD 245.48 Million
|
|
Market Size (2030)
|
USD 330.59 Million
|
|
CAGR (2025-2030)
|
5.19%
|
|
Fastest Growing Segment
|
Companion Animal
|
|
Largest Market
|
North India
|
Market Overview
India Animal Vaccine Market was valued at USD 245.48 Million in 2024 and is anticipated to reach USD 330.59 Million by 2030, with a CAGR of 5.19% during 2025-2030.
This vital industry focuses on the research, production, and distribution of vaccines that protect animal health. These veterinary biologics are indispensable for safeguarding both livestock and companion animals, playing a crucial role in preventing infectious disease outbreaks and ensuring the well-being of India's diverse animal populations.
A primary catalyst for this market growth is the increasing public awareness of animal health and its connection to human safety. As consciousness about zoonotic diseases rises, the demand for preventive measures like vaccination intensifies. In response, governmental bodies are launching proactive initiatives to bolster animal healthcare infrastructure. These policies aim to improve the accessibility and distribution of essential vaccines, thereby strengthening disease control efforts for both commercial livestock and household pets, which in turn supports a healthier public environment for all.
Furthermore, continuous advancements in biotechnology are revolutionizing the development and efficacy of animal vaccines. Cutting-edge methods, including genetic engineering and recombinant DNA technology, are at the forefront of this innovation. These sophisticated techniques enable the creation of highly targeted vaccines that can elicit a powerful and specific immune response against pathogens. This scientific progress not only enhances the effectiveness and safety of modern vaccines but also streamlines the development of new solutions to combat emerging and persistent animal diseases effectively.
Key Market Drivers
Rising Livestock Disease Incidence
The increasing frequency of livestock diseases across India is a primary driver of demand for animal vaccines, as high-density animal populations can accelerate transmission and make rapid, preventive immunization critical to protecting farm incomes and maintaining the continuity of the food supply. India’s livestock production base is large, with total milk production estimated at 239.30 million tonnes in 2023-24, egg production at 142.77 billion numbers in 2023-24, and meat production at 10.25 million tonnes in 2023-24, which raises the economic stakes of disease-related disruptions and intensifies the need for preventive vaccination. For instance, the Government of India reported 41 outbreaks of avian influenza in domestic poultry during 2025 till 24 July 2025 across 10 states, highlighting the recurring outbreak risk that strengthens demand for vaccines and broader biosecurity measures.
The economic consequences of livestock disease outbreaks are substantial, further fueling the need for preventive vaccination, as outbreaks can reduce milk and meat output, affect fertility and productivity, and increase mortality, which directly impacts farmers' earnings. In a sector producing hundreds of millions of tonnes of milk annually, even localized disease shocks can translate into meaningful supply losses and higher healthcare and control costs, reinforcing the value proposition of timely vaccination programs.
Foot-and-mouth disease remains a key focus for vaccination because it can significantly reduce animal productivity and disrupt trade and movement controls during outbreaks.
Avian influenza control has become more prominent, with the Government of India reporting 41 outbreaks in 2025 till 24 July 2025, compared with 49 in 2024, 15 in 2023, 22 in 2022, and 118 in 2021, underscoring the need for ongoing immunization and surveillance-linked response capacity.
Brucellosis remains a priority in preventive animal health programs because it affects reproductive performance and herd productivity, increasing incentives for vaccination and sustained disease-control measures.
Lumpy skin disease and other emerging or resurging infections also increase demand for preventive vaccination because they can cause rapid morbidity and mortality in affected areas, underscoring the need for scalable immunization and outbreak-containment readiness.
Growing Global Pet Adoption
The global trend of rising pet adoption is significantly impacting the demand for animal vaccines in India, as more households adopt dogs and cats and seek preventive healthcare through routine vaccination schedules to protect companion animals from vaccine-preventable diseases. For instance, India’s 20th Livestock Census framework explicitly includes dogs among the domesticated animals counted, and a Government of India written reply reported 153 lakh stray dogs in 2019, indicating a large canine population that requires core preventive vaccination and sustained veterinary public health measures.
Responsible pet ownership, a movement gaining momentum worldwide, strongly advocates for vaccination as a fundamental aspect of animal care, with animal shelters, rescue organizations, and veterinary clinics often requiring core vaccines as part of adoption and wellness protocols. The COVID-19 period also heightened awareness of zoonotic diseases, reinforcing vaccine compliance and regular veterinary engagement among pet-owning communities in India, thereby sustaining demand for companion animal vaccines and aligning with broader animal welfare practices.
Key Industry and Government Initiatives
Government agencies, animal associations, and leading industry players are playing a pivotal role in boosting the demand for animal vaccines in India. Government bodies, such as the Department of Animal Husbandry and Dairying, have launched ambitious nationwide initiatives to control and eradicate major livestock diseases. Programs like the National Animal Disease Control Program (NADCP) implement mass vaccination campaigns against FMD and brucellosis, creating a large-scale, consistent demand for these essential vaccines and strengthening the country's animal health infrastructure.
Alongside government efforts, animal advocacy groups and private-sector leaders are crucial to driving vaccine adoption. Animal welfare associations conduct awareness campaigns to educate farmers and pet owners about the benefits of vaccination for disease prevention. In parallel, top animal healthcare companies invest heavily in research and development to produce innovative and effective vaccines. Through strategic distribution and collaboration with veterinary professionals, these companies ensure that high-quality vaccines are accessible, further stimulating market demand and promoting a culture of proactive animal healthcare.
Expansion of Animal Husbandry
The continuous expansion of animal husbandry in India is a significant driver for the animal vaccine market. As the country's population grows, so does demand for animal-derived products such as milk, meat, and eggs, prompting farmers to increase their livestock holdings. However, larger and more concentrated animal populations inherently carry a higher risk of rapid disease transmission. Consequently, vaccination has become an indispensable practice for protecting animal health, preventing large-scale outbreaks, and maintaining the productivity required to meet rising consumer needs.
Vaccination is increasingly recognized as a cost-effective strategy to protect the economic viability of animal husbandry. Outbreaks of diseases such as FMD or avian influenza can cause catastrophic financial losses for farmers and disrupt the food supply chain. By preventing illness and mortality, vaccines safeguard farmers' investments and ensure the sustainability of their operations. Government support through programs that promote animal husbandry and provide subsidized vaccination further reinforces this trend, solidifying the essential role of vaccines in India's growing agricultural landscape.
Download Free Sample Report
Key Market Challenges
High Vaccine Storage Costs
High storage costs represent a significant restraint on the Indian animal vaccine market. Maintaining vaccine efficacy is critically dependent on a consistent cold chain, but the required infrastructure is expensive. In many rural areas, unreliable electricity and frequent power outages threaten the stability of refrigeration. This makes it difficult to store vaccines at the required temperatures, risking spoilage and rendering them ineffective. The cost of backup power solutions like generators or solar-powered refrigerators is often prohibitively high for individual farmers and small veterinary clinics.
The financial burden of specialized storage facilities further suppresses vaccine demand. Establishing and maintaining cold rooms and dedicated vaccine refrigeration units requires a substantial initial investment and ongoing operational costs. For the millions of small-scale farmers who form the backbone of India's livestock sector, these expenses are often unattainable. This lack of accessible and affordable cold chain infrastructure directly limits the purchase and use of vaccines, creating a major barrier to widespread disease prevention efforts in the country's agricultural heartlands.
Shortage of Skilled Professionals
A critical shortage of qualified veterinarians and skilled farm workers is hampering the demand for animal vaccines in India. Effective vaccination programs depend on the expertise of trained professionals to ensure proper administration, dosages, and scheduling. Without sufficient access to veterinary guidance, many farmers remain unaware of the importance of vaccinations or lack the knowledge to administer them correctly. This information gap leads to improper handling, reduced vaccine efficacy, and a general reluctance to invest in preventive healthcare for their livestock.
The scarcity of skilled farm labor also poses a significant challenge, particularly for implementing large-scale vaccination campaigns. Administering vaccines to large herds or flocks is a labor-intensive process that requires trained assistance. Furthermore, the cost associated with hiring veterinary services can be a major financial barrier for small and marginal farmers. This combination of limited professional access and affordability issues directly contributes to lower vaccination rates, hindering efforts to control animal diseases and protect agricultural productivity across India.
Key Market Trends
Government Initiatives
Proactive government initiatives are a major driver for the Indian animal vaccine market. Through comprehensive disease surveillance, mass vaccination programs, and public awareness campaigns, the government has been instrumental in safeguarding animal health. These concerted efforts, aimed at controlling and eradicating diseases like FMD, directly stimulate demand for vaccines. By prioritizing animal welfare and implementing preventative strategies, these programs create a stable environment for growth in the animal husbandry and veterinary sectors, bolstering the rural economy and ensuring a secure food supply chain.
The government's commitment extends to fostering research and innovation in animal healthcare. By investing in modern research facilities and promoting collaboration between academia, industry, and state agencies, India is cultivating an ecosystem for advanced veterinary science. This focus on technological adoption and skill development has improved the quality of animal care and positioned India as an emerging leader in the global veterinary market. These advancements attract investment, generate employment, and drive the socio-economic development of the nation's agricultural sector.
Technological Advancements
Recent technological advancements are revolutionizing the animal vaccine market by enabling the development of more efficient and targeted vaccines. Innovations using artificial intelligence (AI) and big data analytics are accelerating research and development, significantly improving vaccine efficacy. By analyzing vast datasets on pathogens and immune responses, scientists can design next-generation vaccines faster than ever before. This technological leap is ushering in a new era of proactive disease prevention, protecting animal populations from both existing and emerging health threats.
The impact of this accelerated vaccine development is profound, allowing for rapid responses to disease outbreaks and strengthening public health security. The ability to create and deploy highly effective vaccines quickly helps contain the spread of infectious diseases, including those with zoonotic potential. This paradigm shift empowers veterinary systems to manage health crises more effectively and protect the agricultural economy from the devastating impact of animal pandemics. As these technologies mature, they promise a future of enhanced global health and more resilient food systems.
Segmental Insights
Animal Type Insights
The poultry segment is projected to dominate the Indian animal vaccine market, driven by the nation's substantial and growing consumption of poultry products. As an essential source of protein for a large population, poultry flocks' health is directly linked to food safety and public health. The rapid, exponential growth of the poultry industry to meet this rising demand amplifies the need for effective vaccination programs. Consequently, disease prevention in this sector is not merely an agricultural priority but a critical component of national food security.
This market leadership is also supported by a notable increase in health awareness among poultry farmers. Modern producers understand that proactive, preventive healthcare is essential for maintaining flock productivity and ensuring profitability. They are actively seeking reliable vaccines to protect their birds from costly diseases, viewing vaccination as a crucial investment in their business's sustainability. This combination of high consumption, industry growth, and farmer awareness creates sustained, robust demand for advanced poultry vaccines in the Indian market.
Technology Insights
In terms of technology, recombinant vaccines are poised to lead the Indian market due to their superior design and efficacy. This advanced technology uses recombinant DNA to introduce one or more specific genes into an animal's cells, thereby stimulating a stronger, more targeted immune response. This precision enables the creation of vaccines that are highly effective against specific pathogens. As a result of this well-defined, controlled development process, recombinant vaccines offer greater efficiency and a safer profile than traditional vaccines.
The growing preference for recombinant vaccines among veterinarians is a key factor in their projected market dominance. Professionals are increasingly opting for these solutions due to their reliability and reduced risk of side effects. This trend is amplified by the rising prevalence of complex animal diseases and a greater public understanding of animal health needs. As demand for high-quality veterinary care increases with pet ownership and livestock intensification, recombinant vaccines provide an innovative and effective tool to enhance animal welfare and disease control.
Download Free Sample Report
Regional Insights
The North region of India is poised to dominate the national animal vaccine market, a leadership position attributed to its significant concentration of livestock and poultry farms. States in this region have a deep-rooted agricultural history, supporting a thriving industry where animal health is paramount. The high density of animal populations creates a substantial and consistent demand for vaccines to prevent and control disease outbreaks. This established agricultural infrastructure makes North India a critical hub for vaccine consumption and market growth.
A growing awareness among farmers and animal health professionals regarding the importance of vaccination further solidifies North India's market lead. Farmers increasingly view vaccines not as a cost but as a crucial investment for protecting animal health, boosting productivity, and ensuring farm profitability. This change is driven by educational initiatives and active promotion by veterinarians who emphasize the economic benefits of preventive healthcare, leading to higher adoption rates for vaccination protocols across the region.
The rising consumer demand for animal-derived food products like meat and milk also fuels the need for effective vaccines in North India. As the population's dietary preferences evolve, farmers must maintain healthy and productive livestock to meet this demand sustainably. Vaccination is essential for ensuring animals meet the stringent quality and safety standards required for food production. This market pull ensures a steady demand for vaccines, cementing the region's role in the future of India's animal health industry.
Recent Developments
- In January 2026, Hester reported that during the quarter it capitalised its fill-finish facility, which it said effectively doubled drug product capacity to support growth across domestic and export markets. Hester also said it received marketing and manufacturing licences for its H9N2 Avian Influenza vaccine, strengthening its poultry vaccine portfolio.
- In January 2026, Indian Immunologicals (IIL) announced a pledge of 5 lakh doses of veterinary anti-rabies vaccine for free-roaming dogs under its CSR programme.
- In September 2025, IIL rolled out Raksha‑IBR, described as India’s first indigenously developed gE-deleted DIVA marker vaccine against infectious bovine rhinotracheitis (IBR). The marker/DIVA approach is positioned to help differentiate infected animals from vaccinated animals.
- In September 2025, India's leading veterinary vaccine manufacturers, including Hester Biosciences and Indian Immunologicals, have established the Veterinary Vaccine India Manufacturers Association (VVIMA). This association aims to foster collaboration with policymakers to address industry needs. The veterinary vaccine market in India is currently estimated at ₹2,000 crore (INR 20 billion).
- In February 2025, Biovet, a firm in the Bharat Biotech group, received approval from the Central Drugs Standard Control Organisation (CDSCO) for Biolumpivaxin. This is the world's first DIVA (Differentiating Infected from Vaccinated Animals) marker vaccine for Lumpy Skin Disease (LSD) in cattle and buffaloes. Developed in collaboration with the Indian Council of Agricultural Research (ICAR), the vaccine enables distinction between infected and vaccinated animals and has a planned production capacity of 500 million doses annually.
- On January 10, 2025, a "Conclave on Pandemic Preparedness & Vaccine Innovation" was held in Hyderabad. The event was a collaboration between the Department of Animal Husbandry and Dairying, Indian Immunologicals Limited, and the National Dairy Development Board (NDDB). Key speakers emphasized the need for improved veterinary infrastructure, better diagnostic facilities, and the development of next-generation vaccines to prevent future pandemics and zoonotic disease spillover. The government was also urged to increase spending on animal health and enhance supply chain and cold chain systems for vaccine delivery.
- In November 2024, Boehringer Ingelheim launched a next-generation poultry vaccine in India to target Marek's disease. Recommended for both in-ovo vaccination of eggs and for day-old chicks, the vaccine offers enhanced safety and efficacy against virulent strains of the disease.
Key Market Players
- Biovet Private Ltd.
- Hester Biosciences
Limited
- Intervet India
Private Limited(Merck Limited)
- Indovax Pvt. Ltd
- Bio-Med (P) Limited
- Zoetis India Ltd.
- Brilliant Bio Pharma
Private Limited
- Virbac Animal Health
India Pvt Ltd
- Elanco India Private
Limited
- Ceva Polychem Private Limited
|
By Animal Type
|
By Technology
|
By Disease
|
By Route of
Administration
|
By Distribution
Channel
|
By Region
|
- Livestock
- Swine
- Poultry
- Companion Animals
- Others
|
- Inactive Vaccine
- Live Attenuated
Vaccine
- Toxoid Vaccine
- Recombinant Vaccine
- Others
|
- Foot and Mouth
Disease
- New Castle Disease
- Infectious Bronchitis
- Infectious Bursal
Disease
- Fowl pox
- Rabies
- Others
|
- Subcutaneous
- Intramuscular
- Intraocular
- Oral
- Others
|
- Veterinary Hospitals
- Veterinary Clinics
- Pharmacies
|
|
Report
Scope:
In this
report, the India Animal Vaccine Market has been segmented into the following
categories, in addition to the industry trends which have also been detailed
below:
- India Animal Vaccine Market, By Animal Type:
o
Livestock
o
Swine
o
Poultry
o
Companion Animals
o
Others
- India Animal Vaccine Market, By Technology:
o
Inactive Vaccine
o
Live Attenuated
Vaccine
o
Toxoid Vaccine
o
Recombinant Vaccine
o
Others
- India Animal Vaccine Market, By Disease:
o
Foot and Mouth
Disease
o
New Castle Disease
o
Infectious Bronchitis
o
Infectious Bursal
Disease
o
Fowl pox
o
Rabies
o
Others
- India Animal Vaccine Market, By Route of
Administration:
o
Subcutaneous
o
Intramuscular
o
Intraocular
o
Oral
o
Others
- India Animal Vaccine Market, By Distribution
Channel:
o
Veterinary Hospitals
o
Veterinary Clinics
o
Pharmacies
- India Animal Vaccine
Market, By Region:
o
North
o
South
o
West
o
East
Competitive
Landscape
Company
Profiles: Detailed analysis of the major
companies present in the India Animal Vaccine Market.
Available
Customizations:
India Animal
Vaccine Market report with the given market data, TechSci Research
offers customizations according to a company's specific needs. The following
customization options are available for the report:
Company
Information
- Detailed analysis and profiling of
additional market players (up to five).
India Animal
Vaccine Market is an upcoming report to be released soon. If you wish an early
delivery of this report or want to confirm the date of release, please contact
us at [email protected]